Longevity Researcher Bryan Johnson Diagnosed With Incurable Autoimmune Gastritis

Bryan Johnson, the prominent biohacker who has invested millions in anti-aging research and optimization, has revealed a diagnosis of autoimmune gastritis—a chronic, incurable inflammatory condition that progressively damages stomach tissue. The 48-year-old disclosed the diagnosis after experiencing years of persistent low ferritin levels that his medical team could not initially explain. The revelation underscores a paradox at the heart of longevity science: even those who meticulously monitor and optimize nearly every biological marker can still develop serious, long-term health conditions.

The Hidden Disease

Johnson disclosed his condition through communications with his 1.5 million followers, describing his stomach as "eating itself" due to the autoimmune response. The disease causes what experts describe as "irreversible damage" to the stomach lining and often develops silently over years without noticeable symptoms. He received his diagnosis in May after his team investigated why his iron-storage protein levels remained stubbornly low despite intervention attempts.

According to immunologists at Northeastern University, autoimmune gastritis is not an isolated anomaly. More than 100 known autoimmune diseases exist, each arising when the immune system mistakenly attacks the body's own healthy tissues instead of foreign pathogens. Environmental and genetic factors determine individual susceptibility, though the precise causes of most autoimmune conditions remain poorly understood by the medical community.

The Paradox of Optimization

Johnson's diagnosis presents a significant challenge to the longevity movement's core proposition. He has publicly documented his sleep patterns—claiming more than eight hours nightly—and tracks metrics ranging from sexual function to cardiovascular performance and organ health. Despite this comprehensive biological surveillance, the autoimmune condition progressed undetected for years. Experts note that autoimmune diseases are remarkably common, even among apparently healthy and physically fit individuals, suggesting that conventional health markers do not always capture systemic immune dysfunction.

While autoimmune gastritis is not fatal, medical professionals confirm it carries no cure and increases long-term risk of stomach cancer development. However, most autoimmune conditions can be managed through targeted therapies and lifestyle modifications, meaning Johnson's diagnosis, though serious, may be treatable rather than immediately life-limiting.